Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Marksans Pharma Community
NSEI:MARKSANS Community
1
Narratives
written by author
0
Comments
on narratives written by author
28
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
Marksans Pharma
Popular
Undervalued
Overvalued
Marksans Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Expansion Into US And UK Markets Will Strengthen Future Prospects
Key Takeaways Strategic expansion in the U.S. and U.K., supported by new product launches, aims for long-term growth and improved earnings. Focus on operational efficiencies and stable costs is expected to enhance profit margins and positively impact earnings.
View narrative
₹301.00
FV
29.9% undervalued
intrinsic discount
18.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
MARKSANS
MARKSANS
Marksans Pharma
Your Fair Value
₹
Current Price
₹210.95
18.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
58b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹58.5b
Earnings ₹8.5b
Advanced
Set Fair Value